H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Unicon Pharma Inc

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Unicon Pharma Inc
NJRank #FEIN 46-2554626

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPUnicon Pharma Inc
Total filings80,813679
Certified %98.23%75.55%
Denied %1.09%0.44%
Withdrawn %0.61%1.91%
Cert-withdrawn %0.07%22.09%
Rank#4
Active yearsFY2010–FY2026FY2014–FY2026
Worksite statePANJ

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Unicon Pharma Inc

DOL case-status mix.

Outcome breakdown: Certified 75.6%, Cert-withdrawn 22.1%, Withdrawn 1.9%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified75.6%
Cert-withdrawn22.1%
Withdrawn1.9%
Denied0.4%
Certified75.6%
Cert-withdrawn22.1%
Withdrawn1.9%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Unicon Pharma Inc
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20130
FY201419
FY201555
FY201682
FY201780
FY201872
FY2019107
FY202017
FY202116
FY20224
FY202338
FY202469
FY202572
FY202648

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.